レポート概要

この最新レポートでは、POC市場の主要10セグメントについて、その動態、規模、成長、規制要件、技術動向、競合環境、機器・消耗品サプライヤーにとっての新たな機会などを包括的に分析しています。本レポートはセクション別に提供されており、特定の情報ニーズや予算に合わせてカスタマイズすることも可能です。本レポートは、診断製品サプライヤーが効果的な事業戦略、研究開発戦略、マーケティング戦略を策定するのに役立ちます。

論理的根拠

病院に対する経済的圧力の増大、診断技術の進歩、供給業者や医師間の競争の激化、消費者の要求の変化と相まって、診断検査は病院や商業検査所から患者に近いころへとシフトしてきています。

市場セグメンテーション分析

• POC市場の主要10セグメントについて、そのダイナミクス、トレンド、構造、規模、成長、主要サプライヤーのレビュー
• 以下の市場セグメント別、検査カテゴリー別に、300 を超える化学、免疫診断、微生物学、血液学、凝固検査の 5 年間の検査量と試薬販売予測
  ➣ 市場セグメント別
  　　◇ 自宅/パーソナル検査
  　　◇ 診療室/グループ診療所
  　　◇ 緊急治療室
  　　◇ 手術室/回復室
  　　◇ ICU/CCU
  　　◇ がんクリニック
  　　◇ 外来診療センター
  　　◇ 手術センター
  　　◇ 介護施設
  　　◇ 出産センター
  ➣ 検査カテゴリー別
  　　◇ 日常化学と特殊化学
  　　◇ 微生物学/感染症
  　　◇ 血液学
  　　◇ フローサイトメトリー
  　　◇ 凝固
  　　◇ 免疫タンパク質
  　　◇ 乱用薬物
  　　◇ TDM
  　　◇ 内分泌機能
  　　◇ 腫瘍マーカー

  売上と市場シェアの分析

  • 主要試薬・機器サプライヤーの売上高と市場シェア

  現在の製品と新製品

  • 130 を超える診断手順の分析
  • 化学、免疫測定、血液学、凝固分析など、現在販売されているものから開発中のものまで、主要な分析装置の操作特性、特徴、販売価格などをレビュー

  技術レビュー

  • POC検査向けの新しい技術とその応用
  • POC診断技術と製品を開発または販売している企業の検査別の包括的なリスト

  競争力評価

  • 主要サプライヤーと新興市場参入企業の評価（売上高、製品ポートフォリオ、マーケティング戦略、合弁事業、研究開発中の新製品など）

  戦略的推奨事項

  • 今後 年間で大きな市場訴求力を持つ可能性のある新しいPOC機器および試薬システムの具体的な機会
  • POC検査製品の設計基準
  • 代替ビジネス拡大戦略
  • 潜在的な市場参入障壁とリスク

  方法論

  このレポートは、最近の技術およびビジネス出版物、メーカーの製品資料、業界アナリストレポート、VPGMarketResearch社独自のデータファイルのレビューなど、一次情報源と二次情報源の組み合わせに基づいています。

  レポート詳細

  目次

  Table of Contents
  Introduction
  Executive Summary
  Rationale for Testing Decentralization
  1. Overview
  2. Regulatory Trends
  3. Economic Trends
  4. Demographic Trends
  5. Technological Trends
  6. Social Trends
  7. Quality of Care
  8. Defensive Medicine
  9. Quality Control Issues
  Worldwide Market and Technology Overview
  A. Major Routine Chemistry Tests
  1. Albumin
  2. Alkaline Phosphatase
  3. ALT/SGPT
  4. Ammonia
  5. Amylase
  6. AST/SGOT
  7. Bilirubin
  8. Blood Gases
  9. Blood Urea Nitrogen (BUN)
  10. Calcium
  11. Cholesterol
  12. Cholinesterase
  13. Creatinine
  14. Electrolytes
  a. Carbon Dioxide/Bicarbonate
  b. Chloride
  c. Potassium
  d. Sodium
  15. Ferritin
  16. Follate/Folic Acid
  17. Fructosamine
  18. Gamma-Glutamyl Transpeptidase (GGT)
  19. Glucose
  20. High Density Lipoprotein (HDL)
  21. Iron
  22. Lactate Dehydrogenase (LDH)
  23. Magnesium
  24. Phosphorus
  25. Protein
  26. Triglycerides
  27. Troponin
  28. Uric Acid
  29. Urinalysis
  30. Vitamin B12
  Infectious Disease Tests
  1. AIDS
  2. Adenovirus
  3. Campylobacter
  4. Candida
  5. Chlamydia
  6. Clostridium Difficile
  7. Cytomegalovirus
  8. Enteroviruses
  9. Epstein-Barr Virus
  10. Gonorrhea
  11. Helicobacter Pylori
  12. Hepatitis
  a. Hepatitis A
  b. Hepatitis B
  c. Hepatitis C
  d. Hepatitis D
  13. Herpes Simplex Virus
  14. Human Herpes Virus-6 (HHV-6)
  15. Influenza Viruses
  16. Legionella
  17. Lyme Disease
  18. Measles (Rubeola)
  19. Meningitis
  20. Mononucleosis
  21. Mumps
  22. Mycoplasma
  23. Papillomaviruses
  24. Pneumonia
  25. Respiratory Syncytial Virus (RSV)
  26. Rheumatoid Arthritis
  27. Rotavirus (Reovirus)
  28. Rubella (German Measles)
  29. Salmonellosis
  30. Shigellosis
  31. Staphylococcus Aureus
  32. Streptococci
  33. Syphilis
  Tumor Markers
  1. Alpha-Fetoprotein (AFP)
  2. Carcinoembrionic Antigen (CEA)
  3. Occult Blood
  4. Prostatic Acid Phosphatase (PAP)
  5. Prostate-Specific Antigen (PSA)
  Major Routine and Special Hematology Tests
  1. CBC Analysis
  a. Hemoglobin Concentration
  b. Hematocrit Determination
  c. Red Blood Cell Count
  d. Platelets
  Endocrine Function Tests
  1. Cortisol
  2. Follicle-Stimulating Hormone (FSH)
  3. Gastrin
  4. Human Chorionic Gonadotropin (HCG)
  5. LH
  6. Prolactin
  7. T3
  8. T3 Uptake
  9. Free T3
  10. Thyroxine (T4)
  11. Free T4
  12. TBG
  13. TSH
  Therapeutic Drug Monitoring (TDM)
  1. Overview
  2. Carbamazepine
  3. Digoxin
  4. Gentamicin
  5. Lidocaine
  6. Lithium
  7. Phenytoin/Dilantin
  8. Procainamide
  9. Quinidine
  10. Theophylline
  11. Valproic Acid
  Coagulation Tests
  1. Introduction
  2. Activated Partial Thromboplastin Time (APTT)
  3. Alpha-2 Antiplasmin
  4. Antithrombin III
  5. Bleeding Time
  6. D-Dimer
  7. Factor VIII
  8. Fibrin Degradation Products
  9. Fibrinogen
  10. Heparin
  11. Proteins C and S
  12. Prothrombin Time (PT)
  13. Thrombin Time
  Immunoprotein Tests
  1. CRP
  2. Immunoglobulins
  Drugs of Abuse
  1. Overview
  2. Test Methodologies
  3. Amphetamines
  4. Barbiturates
  5. Benzodiazepines
  6. Cannabinoids/Marijuana
  7. Cocaine
  8. Lysergic Acid Diethylamide (LSD)
  9. Methadone
  10. Methaqualone
  11. Opiates
  12. Phencyclidine
  Instrumentation
  1. Chemistry Analyzers Manufactured by:
  - Abaxis
  - Abbott
  - Alfa Wassermann
  - Awareness Technologies
  - Beckman Coulter/Danaher
  - bioMeriuex
  - Carolina Chemistries
  - Horiba
  - Inverness
  - Medica
  - Nova Biomedical
  - Ortho-Clinical Diagnostics
  - Polimedco
  - Randox
  - Roche
  2. Hematology Analyzers Manufactured by:
  - Abbott
  - Becton Dickinson
  - Beckman Coulter/Danaher
  - Biocode
  - Drew-Scientific
  - Diesse Ves Matic
  - Horiba
  - Menarini
  - Nihon Kohden
  - Polymedco
  - Sysmex
  3. Coagulation Analyzers Manufactured by:
  - Behnk Elektronik
  - Bio/Data
  - Cardiovascular Diagnostics
  - Diagnostica Stago
  - Helena Laboratories
  - Instrumentation Laboratory
  - ITC Hemochron
  - Roche
  - Siemens
  - Sysmex
  - Teco Medical Instruments
  - Trinity Biotech
  Current and Emerging Technologies
  1. Monoclonal Antibodies
  2. Immunoassays
  a. Technological Principle
  b. Enzyme Immunoassays (EIA)
  Overview
  ELISA
  Dot Immunobinding Assays
  Capillary Immunoassays
  Particle-Membrane Capture Immunoassay
  Enzyme Amplification
  c. Fluorescent Immunoassays
  Fluorescent Polarization
  Time-Resolved Pulse Fluorescence
  d. Luminescence
  Chemiluminescence
  Bioluminescence
  e. Latex Agglutination
  f. Immunoprecipitation
  3. Dry Chemistry
  4. Biosensors
  5. IT and Automation
  6. Molecular Diagnostics
  a. Technology Overview
  b. Amplification Methods
  Polymerase Chain Reaction
  Ligase Chain Reaction
  Branched DNA
  Q-Beta Replicase
  Strand Displacement Activation
  Self-Sustained Sequence Replicase
  Worldwide Business Environment
  U.S.A.
  A. Market Overview
  1. Business Environment
  a. Health Care Expenditures
  b. Cost Consciousness
  c. Reimbursement
  d. Industry Consolidation
  e. Managed Care
  PPO
  HMO
  f. Hospitals
  g. Admissions
  h. Length of Stay
  i. Industry Diversification
  j. Physician Demographics
  k. Aging Population
  More Chronic Illness
  Disease Incidence
  Susceptibility to latrogenesis
  Multiple Illnesses Cases
  l. Laboratory Regulations
  2. Market Structure
  a. Hospitals
  b. Commercial/Private Laboratories
  B. Personal Testing
  1. Glucose Monitoring
  Market and Technology Overview
  Invasive Testing
  Non-Invasive Testing
  Genetic Testing
  2. Pregnancy Tests
  3. Occult Blood Tests
  4. Market Size and Growth
  C. Physician Offices/Group Practices
  1. Market Summary
  2. Market Structure
  3. Test Volume and Sales Forecasts
  D. Ancillary Hospital Locations
  1. Introduction
  a. Emergency Departments
  b. Operating Suites
  c. Intensive Care Units
  2. Emergency Departments
  a. Market Summary
  b. Test volume and Sales Forecasts
  3. Operating and Recovery Suites
  a. Market Summary
  b. Test Volume and Sales Forecasts
  4. ICUs/CCUs
  a. Market Summary
  b. Test Volume and Sales Forecasts
  E. Cancer Clinics
  1. Introduction
  2. Market Summary
  3. Test Volume and Sales Forecasts
  F. Ambulatory Care Centers
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts
  G. Surgery Centers
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts
  H. Nursing Homes
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts
  I. Birth Centers
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts
  J. Major Suppliers’ Instrument Placements,
  Installed Base, Consumables Sales and Market Shares
  Major Product Development Opportunities
  A. Routine and Special Chemistry
  B. Microbiology/Infectious Diseases
  C. Hematology and Flow Cytometry
  D. Coagulation
  Design Criteria for Decentralized Testing Products
  Alternative Market Penetration Strategies
  A. Internal Development
  B. Collaborative Arrangements
  C. University Contracts
  D. Distribution Strategies for Decentralized
  Testing Markets
  1. Marketing Approaches
  2. Product complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation
  Potential Market Entry Barriers and Risks
  A. Market Maturity
  B. Cost Containment
  C. Competition
  D. Technological Edge and Limitations
  E. Patent Protection
  F. Regulatory Constraints
  G. Decentralized Testing Market Challenges
  Company Profile
  Abbott
  Agilent Technologies
  Beckman Coulter/Danaher/Cepheid
  Becton Dickinson
  Bio/Data
  bioMerieux
  Bio-Rad
  Chrono-Log
  Corgenix
  Decode Genetics
  Diagnostica Stago
  Diamedix
  DiaSorin
  Eiken Chemical
  EKF Diagnostics
  Fujifilm Wako
  Fujirebio
  Grifols
  Helena Laboratories
  Hologic
  Horiba
  Instrumentation Laboratory/Werfen
  Kyowa Medex
  Labcorp
  Leica Biosystems
  Lonza
  Nihon Kohden
  Polymedco
  Qiagen
  QuidelOrtho
  Roche
  SDIX
  Sekisui Diagnostics
  Siemens Healthineers
  Sienco
  Sysmex
  Takara Bio
  Thermo Fisher
  Tosoh

  U.S.A., CA 19-9 Testing Market by Major Suppliers
  U.S.A., CEA Testing Market by Major Suppliers
  U.S.A., PAP Testing Market by Major Suppliers
  U.S.A., PSA Testing Market by Major Suppliers
  List of Tables (continued)
  U.S.A., Hematology Analyzers
  Estimated Placements and Installed Base
  U.S.A., Flow Cytometers
  Estimated Placements and Installed Base
  U.S.A., Hematology Diagnostics Market
  Estimated Market Shares of Major Suppliers
  U.S.A., Hematology Instrument Market
  Estimated Market Shares of Major Suppliers
  U.S.A., Hematology Consumable Market
  Estimated Market Shares of Major Suppliers
  U.S.A., Flow Cytometry Diagnostics Market
  Estimated Market Shares of Major Suppliers
  U.S.A., Flow Cytometry Consumable Market
  Estimated Market Shares of Major Suppliers
  U.S.A., Flow Cytometry Instruments Market
  Estimated Market Shares of Major Suppliers
  U.S.A., Major Suppliers of Coagulation
  Diagnostic Products, Estimated Market Shares
  of Major Suppliers